Integra LifeSciences Appoints Essig CEO, Adds Commercial Chief
Integra LifeSciences is bringing back a longtime leader to steer its next phase. The medical technology company appointed Stuart M. Essig as permanent President and Chief Executive Officer, while naming Michael McBreen to the newly created role of Chief Commercial Officer. Essig, who will remain Chairman of the Board, succeeds Mojdeh Poul as she departs the company to pursue other opportunities. Presiding Director Barbara Hill said the board does not intend to launch a CEO search, calling Essig’s appointment “the right leadership step for the company’s next phase”…